News

< Back

Announcing AFAR's 2025 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss Recipients

Announcing AFAR's 2025 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss Recipients

AFAR and the McKnight Brain Research Foundation are pleased to announce the recipients of the 2025 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss:

Leah Acker, MD, PhD

Assistant Professor, Duke University

Erin Gibson, PhD

Assistant Professor, Stanford School of Medicine


The Innovator Awards program funds research scientists pursuing groundbreaking studies in the field of cognitive aging. Now in its fifth year, the successful grant program has already supported eight investigators in previous years through the collaboration and support of AFAR and the McKnight Brain Research Foundation. Dr. Acker and Dr. Gibson will each receive $750,000 for an award period of three years.

Dr. Acker's research project is titled "Inflammatory Hangover and Cognitive Aging." As a practicing neurosurgical anesthesiologist and scientist, she leads the Anesthesiology, Cognitive Neuroscience, and Engineering Research (ACkER) Lab at Duke University. The ACkER Lab is rethinking how to protect the aging brain before, during, and after surgery. Her multi-disciplinary team studies how the brain, heart, and immune system communicate to support recovery and long-term brain health. Using wearable sensors, brainwave recordings, and gentle, noninvasive nerve stimulation, they explore how small, repeated bouts of inflammation may quietly accelerate cognitive aging—a phenomenon called “the inflammatory hangover”—and how to prevent it. By translating discoveries in brain–body communication into practical tools, the ACkER Lab aims to help older adults recover from physiological stress more quickly, think more clearly, and maintain independence longer.

Explore more of Dr. Acker’s research on her lab’s website here.

Dr. Gibson's research project is titled “NSPR1 as an intersectional regulator of myelin and cognition in aging." Dr. Gibson’s research focuses on myelin-forming oligodendroglia, the cells that wrap around and insulate the axons connecting neurons, allowing for efficient neural communication within the brain. Specifically, her lab aims to understand how these cells contribute to the regulation of sleep and cognition in aging. Her lab identified alterations in neuropeptide S signaling, a known regulator of sleep and cognition, in oligodendrocytes with aging. Her AFAR-supported research focuses on deciphering the role of neuropeptide S signaling between neurons and oligodendroglia in the regulation of sleep, and how this may change with aging and contribute to aging-associated cognitive decline.

Explore more of Dr. Gibson’s research on her lab’s website here.

Learn more about the McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss here.

AFAR is grateful to the McKnight Brain Research Foundation for their support of this grant program.

More Recent News

View All News >
AFAR Experts in the News: Scientific Director Steven N. Austad, PhD, and Irving Wright Award Recipient S. Jay Olshansky, PhD on a new Blue Zone in Sardinia -–and its cues to Women’s Longevity--featured in Frontiers in Aging and National Geographic.
AFAR Experts in the News: Scientific Director Steven N. Austad, PhD, and Irving Wright Award Recipient S. Jay Olshansky, PhD on a new Blue Zone in Sardinia -–and its cues to Women’s Longevity--featured in Frontiers in Aging and National Geographic.
AFAR Experts in the News: New paper co-authored by Scientific Director Steven N. Austad, PhD, and Grantees Matt Kaeberlein, PhD, and Richard A. Miller, MD, PhD, published in Frontiers in Science explores potential aging rate indicators
AFAR Experts in the News: New paper co-authored by Scientific Director Steven N. Austad, PhD, and Grantees Matt Kaeberlein, PhD, and Richard A. Miller, MD, PhD, published in Frontiers in Science explores potential aging rate indicators
AFAR Grantee in the News: New research co-authored by Omer Sharon, PhD, on sleep loss, tau buildup and aging related memory loss published in Nature Neuroscience.
AFAR Grantee in the News: New research co-authored by Omer Sharon, PhD, on sleep loss, tau buildup and aging related memory loss published in Nature Neuroscience.
AFAR Grantee in the News: New research co-authored by Qinchuan Wang, PhD, on protein and age-related muscle dysfunction in Aging Cell.
AFAR Grantee in the News: New research co-authored by Qinchuan Wang, PhD, on protein and age-related muscle dysfunction in Aging Cell.
Board Member in the News: Nir Barzilai, MD, featured in National Geographic on the potential of GLP-1 drugs as gerotherapeutics.
Board Member in the News: Nir Barzilai, MD, featured in National Geographic on the potential of GLP-1 drugs as gerotherapeutics.
AFAR Experts in the News: Nature Aging publishes new research co-authored by multiple AFAR Grantees on the connection between the protein cyclin D1 in senescent cells and age-related diseases.
AFAR Experts in the News: Nature Aging publishes new research co-authored by multiple AFAR Grantees on the connection between the protein cyclin D1 in senescent cells and age-related diseases.
AFAR News: 45th Anniversary and 2025 Annual Report Out Now
AFAR News: 45th Anniversary and 2025 Annual Report Out Now
AFAR Grantee in the News: New research co-authored by Kristopher Burkewitz, PhD, on mitochondrial dysfunction and lifespan in Nature Communications.
AFAR Grantee in the News: New research co-authored by Kristopher Burkewitz, PhD, on mitochondrial dysfunction and lifespan in Nature Communications.
AFAR Experts in the News: TIME’s Longevity Leaders 2026 List spotlights Nir Barzilai, MD, Jamie L. Justice, PhD, and more.
AFAR Experts in the News: TIME’s Longevity Leaders 2026 List spotlights Nir Barzilai, MD, Jamie L. Justice, PhD, and more.